---
title: 'Duke-FDA Public Workshop: Pharmacodynamic Biomarkers for Biosimilar Development
  and Approval'
author: ''
date: '2021-09-20'
slug: duke-fda-public-workshop-pharmacodynamic-biomarkers-for-biosimilar-development-and-approval
categories: []
tags: []
type: conference
url_freeregister: https://healthpolicy.duke.edu/events/biosimilar
url_slides: ~
url_code: ~
url_pdf: ~
url_video: ~
url_website: ~
url_agenda: ~
location: Virtual
address:
  street: ~
  city: ~
  region: ~
  postcode: ~
  country: ~
date_end: '2021-09-21'
all_day: yes
publishDate: '2021-09-12T16:04:29-07:00'
authors: []
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
slides: ''
projects: []
summary: ~
abstract: ~
---

<!--more-->
**Workshop Objectives**
- Discuss the current and potential future state of leveraging PD biomarkers for biosimilar development and approval   
- Summarize FDA’s initiatives to advance biosimilar development   
- Describe stakeholders’ experience with PD biomarkers in biosimilar development    
- Explain research efforts to promote a broader application of PD biomarkers in biosimilar development  